Could a single eye implant replace years of glaucoma drops?
Disease control
Recruiting now
This trial tests a new implant that slowly releases the glaucoma drug timolol inside the eye. It is for people with open-angle glaucoma or ocular hypertension who are already having cataract surgery. The study compares three doses of the implant against standard timolol eye drops…
Phase: PHASE1, PHASE2 • Sponsor: EyeD Pharma • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC